NCT00295815 2019-09-12Enzastaurin Versus Lomustine in GlioblastomaEli Lilly and CompanyPhase 3 Completed397 enrolled
NCT00332202 2018-09-10PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinEli Lilly and CompanyPhase 3 Completed758 enrolled 20 charts